Annex 13 – Manufacture of Investigational Medicinal Products

USD $35.00

Course duration: Allow 2 to 4 hours to complete this course.

  • Check Mark Satisfaction Guaranteed
  • Check Mark No Hassle Refunds
  • Check Mark Secure Payments
GUARANTEED SAFE CHECKOUT
  • Stripe
  • Visa Card
  • MasterCard

Description

PIC/S Annex 13: Manufacture of Investigational Medicinal Products (IMPs) Online GMP Trainingย 

Course Overview

PIC/S Annex 13 guidance outlines the Good Manufacturing Practice (cGMP) requirements for the manufacture of Investigational Medicinal Products (IMPs).

This interactive eLearning module provides a comprehensive understanding of the latest regulatory updates to PIC/S Annex 13 and provides learners with a current GMP Training Certificate for this GMP education topic. Note: recent PIC/S updates to Annex 13 for IMPs went into effect on 1 February 2022.

What is an IMP? Definition of IMPs (FDA): ย An investigational medicinal product (IMP) is a drug or placebo that is being tested or used as a reference in a clinical trial.ย The FDA, similar to other regulatory authorities, regulates the manufacturing and handling of IMPs to ensure their safety and quality.

Many regulators refer to PIC/S Annex 13 when conducting regulatory compliance site inspections of facilities, processes, procedures and training records.

Examples of Investigational Medicinal Products (IMPs):

  • New drugs in various stages of development
  • Licensed drugs being tested for new conditions
  • Licensed drugs being tested in new formulations or packaging
  • Licensed drugs being used to gather more information, e.g., researching additional medicine safety information and/or dosing parametersย 

Regulatory Compliance Requirements for IMPs

This GMP eLearning course will help you learn about:
โœ… Manufacturing & Distribution โ€“ IMPs and comparator products for Clinical Trials
โœ… Regulatory Requirements โ€“ Compliance with cGMP and PIC/S Annex 13 standards
โœ… Batch Certification & Release โ€“ Authorised Person (AP) responsibilities for IMPs (Our PIC/S Annex 16 Online GMP Training course has further details for Authorised Persons & Batch Release)
โœ… Blinding & Unblinding Mechanisms โ€“ Single-blind, double-blind, and emergency unblinding codes
โœ… Preparation & Packaging โ€“ Repackaging, labelling, and distribution controls
โœ… Recordkeeping & Reporting โ€“ Documentation and compliance measures

This self-paced online GMP compliance course covering PIC/S Annex 13 is designed for Sponsors, medical personnel, quality teams, clinical researchers, drug development and drug manufacturing professionals who are involved with IMPs and/or Clinical Trials of new medicines under investigation.

Who Should Take This Course?

This PIC/S GMP Training course covering Annex 13 is essential for professionals, clinicians and laboratory personnel who work with Investigational Medicinal Products (IMPs) & GMP compliance roles, including:
โœ… Quality & Manufacturing Personnel Responsible for Batch Release
โœ… Clinical Trial Sponsors, Managers & Coordinators
โœ… Medicinal Product & Placebo Developers & Healthcare Researchers
โœ… Pharmacovigilance & Regulatory Affairs Professionals
โœ… GMP Compliance Inspectors & Auditors
โœ… Drug Developers including Advanced Therapy Medicinal Product (ATMP) Developers
โœ… Logistics Managers & Distribution Teams for IMPs
โœ… Medical Device & Biopharmaceutical Manufacturing Personnel

Key Learning Topics for PIC/S Annex 13 (IMPs)ย ย 

๐Ÿ“Œ Common Terminology in IMP Manufacturing โ€“ Definitions and key concepts
๐Ÿ“Œ Regulatory Requirements for IMP Manufacturing & Distribution โ€“ Compliance with PIC/S Annex 13
๐Ÿ“Œ Validation & Quality Management โ€“ Expectations for IMPs in Clinical Trials
๐Ÿ“Œ Personnel Responsibilities & Training โ€“ GMP compliance for IMP teams
๐Ÿ“Œ Cross-Contamination Prevention โ€“ Best practices for IMP manufacturing
๐Ÿ“Œ Product Specification File (PSF) Requirements โ€“ Essential documentation
๐Ÿ“Œ Complaints, Recalls & Returns โ€“ Regulatory procedures for IMPs

PICS-Annex-13-IMPS-clinicaltrialrules-

Why This Course is Essential for GMP Compliance

Many regulatory agencies, such as the FDA, EMA, MHRA, and TGA, require strict adherence to PIC/S Annex 13 for the manufacture and handling of IMPs.

This course provides essential training on:
โœ”๏ธ Regulatory expectations for IMP manufacturing, validation & documentation
โœ”๏ธ Best practices for blinding, unblinding, and comparator product handling
โœ”๏ธ Batch certification & release responsibilities of the Authorised Person
โœ”๏ธ GMP inspections and regulatory oversight for IMP processes

Certificate GMP Courseย 

  • Successful completion of theย Final Assessment for this PIC/S Annex 13 course provides you with a downloadable & printable Certificate of Completion.
  • This Certificate should be added to your GMP training records.
  • You can also attach your GMP training certificate to your CV when applying for job openings or research positions.

Flexible Online Learning Format

Thisย self-paced eLearning courseย allows participants to:
โœ”๏ธย Access course materials 24/7ย after purchase (valid for 12 months)
โœ”๏ธย Complete the training at their own paceย with practical case studies
โœ”๏ธย Combine online learning with instructor-led training optionsย (virtual or onsite, where available)

This course is ideal for professionals involved in Clinical Trials, IMP manufacturing, and regulatory compliance within the pharmaceutical, biotechnology, and medical device industries.

Additional GMP Compliance Training & Laboratory Personnel Training Courses Resources